« Previous
Next »
International Journal of Antimicrobial Agents
Volume 36, Issue 1
, Pages 19-23
, July 2010
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals
References
- . The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect. 2008;14(Suppl. 1):33–41
- . Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52–59
- . Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–166
- Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis. 2008;14:195–200
- Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61:273–281
- Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12:83–88
- . Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother. 2009;53:2846–2851
- . Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53:2227–2238
- Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother. 2009;63:67–71
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
- Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother. 2007;51:1281–1286
- . qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006;50:2872–2874
- . Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6′)-Ib-cr. J Antimicrob Chemother. 2008;61:999–1002
- Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol. 2005;43:1045–1050
- Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
- . Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J Clin Microbiol. 2009;47:1212–1215
- Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother. 2009;64:274–277
- . Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–4558
- . Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother. 2005;49:4667–4670
- . Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–228
- . Extended-spectrum β-lactamases in North America, 1987–2006. Clin Microbiol Infect. 2008;14(Suppl. 1):134–143
- . Discovery of CTX-M-like extended-spectrum β-lactamases in Escherichia coli isolates from five US States. Antimicrob Agents Chemother. 2003;47:2382–2383
- . Prevalence of newer β-lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol. 2006;44:3318–3324
- . First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother. 2007;51:4015–4021
- . Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist. 2008;14:211–216
- . Emergence of extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States?. Clin Infect Dis. 2009;49:e30–e32
- . Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother. 2008;52:3814–3816
- . Community-acquired extended-spectrum β-lactamase producers, United States. Emerg Infect Dis. 2007;13:1121–1123
- . Prevalence of CTX-M β-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol. 2009;47:2970–2974
- Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009;53:4733–4739
- . Extended-spectrum β-lactamases in long-term-care facilities. Clin Microbiol Infect. 2008;14(Suppl. 1):111–116
- CTX-M-15-producing Escherichia coli in the United States: predominance of sequence type ST131 (O25:H4). In: Proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25–28 October 2008, Washington, DC. Washington, DC: ASM Press; 2008;[Abstract K-3444]
- . Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol. 1990;172:6175–6181
- . Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis. 2001;183:78–88
PII: S0924-8579(10)00100-7
doi: 10.1016/j.ijantimicag.2010.02.016
© 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
« Previous
Next »
International Journal of Antimicrobial Agents
Volume 36, Issue 1
, Pages 19-23
, July 2010
